Global Knee Bursitis Market Projected to Surpass $3.79 Billion by 2029 with 7.3% Annual Growth

What Are the Market Size and Growth Forecast for the Knee Bursitis Market?
In the past few years, the market for knee bursitis has experienced robust expansion. The market is projected to increase from $2.66 billion in 2024 to $2.86 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The significant growth during the historical timespan can be credited to factors such as the ageing population, heightened involvement in sports and physical activities, advancements in diagnostic procedures, better accessibility to healthcare facilities, and educational initiatives for healthcare providers and patients.

The market size for knee bursitis is projected to witness robust expansion in the forthcoming years, with an estimated value of $3.79 billion by 2029, growing at a CAGR of 7.3%. Factors contributing to this growth in the predicted period include heightened consciousness and campaigns related to prevention and management, growth in disposable income, increased healthcare spending, and enhanced awareness and diagnosis of knee bursitis. Key trends to watch in this forecast period encompass innovations in diagnostic methodologies, creation of new treatment methods, progress in R&D activities, and the application of telemedicine and remote surveillance.

What Factors Are Fueling Growth in the Knee Bursitis Market?
The knee bursitis market is predicted to see significant growth due to the rising incidence of bone-related diseases. These conditions, which include osteoporosis, arthritis, and bone cancer, negatively affect the integrity, strength, and function of the skeletal system. Contributing factors to the rise in bone-related diseases are aging populations, sedentary lifestyles, improper nutrition, and environmental alterations. Osteoarthritis and rheumatoid arthritis, in particular, can lead to knee bursitis by triggering inflammation and excessive knee bursa pressure, causing pain, swelling, and impaired joint function. As an example, a report from Healthy Bones Australia projected that in 2022, about 6.2 million Australians over the age of 50 would be affected by osteoporosis or osteopenia. The report noted that within the 4.74 million Australians with poor bone health, 22% have osteoporosis and 78% have osteopenia. Thus, the escalation in bone-related disorders is fueling the expansion of the knee bursitis market. Another major factor driving the knee bursitis market's growth is the rising diabetic population. Diabetes is a chronic disease characterized by the body's inability to properly control blood sugar levels due to insufficient insulin production or ineffective insulin utilization. The factors that account for the increase in diabetes cases encompass sedentary lifestyles, poor dietary practices, and genetic factors. Knee bursitis may be developed by diabetes patients due to prolonged pressure on the knees, a weakened immune system, or diabetes-associated complications. For instance, the National Health Service reported in June 2024 that the number of individuals pre-registered for diabetes in the UK rose by 18% to 3,615,330 in 2023, up from 3,065,825 in 2022. Consequently, the growing diabetic population is propelling the knee bursitis market forward.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Which Key Market Leaders Are Driving Knee Bursitis Industry Growth?
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

What Are the Main Segments in the Knee Bursitis Market?
The knee bursitis market covered in this report is segmented -

1) By Diagnosis: Imaging Test, Other Diagnosis Tests
2) By Treatment: Medication, Therapy, Surgery, Other Treatments
3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:
1) By Imaging Test: X-Ray, MRI (Magnetic Resonance Imaging), Ultrasound
2) By Other Diagnosis Tests: Physical Examination, Aspiration Of Joint Fluid, Blood Tests

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Which Geographic Area Leads the Knee Bursitis Market?
North America was the largest region in the knee bursitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Knee Bursitis Global Market Report?

- Market Size Analysis: Analyze the Knee Bursitis Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Knee Bursitis Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Knee Bursitis Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Knee Bursitis Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.